Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Huntington's Disease
100%
Gene Expansion
56%
Disease Genes
35%
Cerebrospinal Fluid
17%
Social Cognition
14%
Premanifest Huntington's Disease
13%
HD Gene
13%
Executive Function
13%
Cognitive Impairment
13%
Spinocerebellar Ataxia
12%
Cognitive Symptoms
12%
Premanifest
11%
Pre-manifest
11%
Motor Symptoms
11%
Progressive multiple Sclerosis
10%
T Helper
10%
Intrathecal
10%
Mutant Huntingtin (mHTT)
10%
Disease Burden
10%
Burden Test
8%
Ataxia
8%
Denmark
8%
Neurodegeneration
8%
Healthy Controls
7%
Mini-Mental State Examination
7%
Motor Onset
7%
Social Cognitive Deficits
6%
Clinical Cohort
6%
Cerebellar Ataxia
6%
Leukocytes
6%
Cerebrospinal Fluid Biomarkers
6%
Neurofilament Light (NF-L)
6%
CSF Biomarkers
5%
Myelin Basic Protein
5%
6-year Follow-up
5%
Emotion Recognition
5%
Emotion Theory
5%
Sarcasm Detection
5%
Neuropsychiatric Impairment
5%
Cancer Incidence
5%
Disease Analysis
5%
Registry Study
5%
Peripheral Leukocytes
5%
Functional Decline
5%
Theory of Mind
5%
Oxytocin
5%
Biochemical Analysis
5%
Blood-brain Barrier Integrity
5%
Clinical Classification
5%
Inflammation Biomarkers
5%
Neuroscience
Huntington's Disease
65%
Cognitive Disorders
16%
Biological Marker
14%
Intrathecal
13%
Ataxia
13%
Psychopathology
11%
Leukocyte
10%
Huntingtin
8%
Magnetic Resonance Imaging
7%
Cytokine
7%
Enzymes
6%
Chemokine
6%
Neurodegenerative Disorder
5%
Gene Dosage
5%
Personality Traits
5%
Nuclear DNA
5%
Metabolic Pathway
5%
Oxytocin
5%
Mitochondrial DNA
5%
Gene Mutation
5%
Spinocerebellar Ataxia
5%
Muscle Atrophy
5%
Fluorine-18
5%
Montreal Cognitive Assessment
5%
Positron Emission Tomography
5%
Catecholamine
5%
Cell Activity
5%
Primary Progressive Multiple Sclerosis
5%
Polyglutamine
5%
Blood Brain Barrier
5%
Neuropathy
5%
Genetics
5%
